Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas.

Medical science monitor : international medical journal of experimental and clinical research - 1 Jul 2011

Schroner Zbynek, Dobrikova Martina, Klimcakova Lucia, Javorsky Martin, Zidzik Jozef, Kozarova Miriam, Hudakova Terezia, Tkacova Ruzena, Salagovic Jan, Tkac Ivan

Abstract excerpt

BACKGROUND: We aimed to analyse quantitative effects of treatment with sulphonylurea in addition to metformin on parameters of glycemic control in relation to KCNQ1 genotypes, and to identify factors predictive for the response to sulphonylurea treatment. MATERIAL/METHODS: Effect of 6-month sulphonylurea therapy in addition to metformin on glycemic control according to KCNQ1 genotypes was evaluated in 87 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to KCNQ1 Potassium Channel

Share to Linear Models

Share to Metformin

Share to Pharmacogenetics

Share to Sulfonylurea Compounds

Source

Open in PubMed Open full text

Identifiers

PMID: 21709633
DOI: 10.12659/msm.881850
PMCID: PMC3539557

Genes

KCNQ1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas.PMID 21709633Read ↗

Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas.Semantic proximity Read ↗

Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.Semantic proximity Read ↗

KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors.Semantic proximity Read ↗

KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.Semantic proximity Read ↗

Genetic Variants Identified from GWAS for Predisposition to Type 2 Diabetes Predict Sulfonylurea Drug Response.Semantic proximity Read ↗

The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 weeks follow-up study.Semantic proximity Read ↗

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetesSemantic proximity Read ↗

Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.Semantic proximity Read ↗

Impact of PRKAA2 and LKB1 genetic variants on metabolic alterations in response to metformin-sulfonylurea therapy.Semantic proximity Read ↗

Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.Semantic proximity Read ↗

Combined Influence of Genetic Variants and Gene-gene Interaction on Sulfonylurea Efficacy in Type 2 Diabetic Patients.Semantic proximity Read ↗

Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.